Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Celebrex Educational Campaign Or Name Change Expected By End Of May

Executive Summary

A decision on instituting a name change or educational campaign for Searle/Pfizer's Celebrex is expected by the end of May.
Advertisement

Related Content

Celebrex Name Keeps Drug Off Minnesota Health-System Formulary
Celebrex Name Keeps Drug Off Minnesota Health-System Formulary
Vioxx Strategy Aims To Switch Patients Up From OTC To Rx Market
Vioxx Strategy Aims To Switch Patients Up From OTC To Rx Market
Celebrex Branded DTC Campaign Launches In 50 Publications
Celebrex Branded DTC Campaign Launches In 50 Publications
Advertisement
UsernamePublicRestriction

Register

PS034113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel